Bacteria that cause common urinary-tract infections are increasingly developing resistance to existing antibiotics. Soon, a new treatment option could be available.
GSK PLC said its experimental treatment for uncomplicated urinary-tract infections was effective in two large clinical trials, paving the way for what could be the first new oral antibiotic for the common ailment in more than two decades.
Around half of all women have suffered a urinary-tract infection, or UTI, at least once, and recurrence is common, according to studies. UTIs are typically treated with antibiotics, but some bacteria have developed resistance to existing drugs, creating a need for new treatment options.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New antibiotic appears to be effective against urinary tract infections, drug company says | CNNThe first new type of antibiotic developed in more than 20 years to treat urinary tract infections (UTIs) appears to be so effective that the pharmaceutical company stopped testing and will soon submit its data to the US Food and Drug Administration for approval.
Read more »
How to get rid of UTI: FDA to consider new antibiotic for urinary tract infectionsGepotidacin works by blocking enzymes that bacteria need to unzip their DNA -- their operating instructions -- so they can multiply in the body.
Read more »
How to get rid of UTI: FDA to consider new antibiotic for urinary tract infectionsGepotidacin works by blocking enzymes that bacteria need to unzip their DNA -- their operating instructions -- so they can multiply in the body.
Read more »
How to get rid of UTI: FDA to consider new antibiotic for urinary tract infectionsGepotidacin works by blocking enzymes that bacteria need to unzip their DNA -- their operating instructions -- so they can multiply in the body.
Read more »
Recurrent Urinary Tract Infections: What's Good Prophylaxis?A discussion with the patient about risk factors can provide significant benefit. Antibiotic prophylaxis should be considered a last resort.
Read more »